Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag symbols : Mor save search
Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.32%
H: 0.48%
C: -0.17%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.32%
H: 0.04%
C: -0.56%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
for novartis
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Published: 2024-03-22 (Crawled : 08:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -0.01%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.94%
H: 0.11%
C: -0.11%
acquisition clearance novartis
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
Published: 2024-02-05 (Crawled : 22:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: -1.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.15%
H: 0.6%
C: 0.42%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 1.39%
H: 0.34%
C: -7.08%
pipeline acquire novartis agreement
Incyte to Spotlight More Than 40 Hematology and Oncology Abstracts Including a Plenary Presentation at the ASH Annual Meeting
Published: 2023-11-02 (Crawled : 18:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.09%
H: 1.03%
C: 0.91%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.32%
H: 0.45%
C: -1.19%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 2.22%
H: 0.6%
C: -9.4%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.28%
H: 1.0%
C: -0.46%
presentation meeting
Incyte Announces Data from Across its Oncology Portfolio will be Presented at the AACR Annual Meeting 2023
Published: 2023-03-14 (Crawled : 01:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: 0.31%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.2%
H: 0.17%
C: -1.67%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -1.79%
H: 3.39%
C: 3.39%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.18%
H: 1.06%
C: 0.94%
meeting
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting
Published: 2022-05-26 (Crawled : 11:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.5%
H: 2.14%
C: 0.19%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.26%
H: 0.95%
C: -1.13%
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 2.08%
H: 1.96%
C: -0.77%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 2.45%
H: 0.92%
C: -2.03%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 2.12%
H: 4.06%
C: 1.39%
results
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-08-03 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: -0.6%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: 0.17%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.55%
H: 1.32%
C: 1.03%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -2.43%
H: 0.88%
C: 0.44%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.7%
H: 0.31%
C: 0.04%
financial results results
BioSpace Movers & Shakers, May 21
Published: 2021-05-21 (Crawled : 15:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.24%
C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.52%
H: 1.19%
C: -0.07%
XERS | $1.73 -1.7% -1.73% 2M
|
Health Technology
|
| O: 1.71%
H: 0.61%
C: -2.53%
TELA | $4.76 -7.57% -8.19% 120K
|
Health Technology
|
| O: 1.36%
H: 4.17%
C: -1.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 2.21%
H: 0.0%
C: -0.46%
IART | $28.68 -9.33% -10.29% 2.9M
|
Health Technology
|
| O: -0.32%
H: 1.67%
C: -0.61%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 0.98%
H: 2.74%
C: 1.71%
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 0.77%
H: 3.05%
C: 0.38%
space spac
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: -1.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.82%
H: 0.28%
C: -0.06%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: -5.61%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -4.71%
H: 0.33%
C: -2.65%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -2.37%
H: 2.04%
C: -2.95%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.